100
Participants
Start Date
July 27, 2023
Primary Completion Date
December 31, 2025
Study Completion Date
June 30, 2026
Guanfacine Extended Release Oral Tablet
Target dose 4 mg daily
Residential withdrawal
4-14 days in residential withdrawal treatment
Engagement with alcohol and other drug services
Ongoing engagement with a youth drug and alcohol service for counselling or other support for the duration of the study
Placebo
Placebo capsule taken daily
RECRUITING
Orygen, Parkville
Lead Sponsor
Youth Support and Advocacy Service
UNKNOWN
University of Melbourne
OTHER
Orygen
OTHER